We are live on ! Find out more
RP

Riverbridge Partners Portfolio holdings

AUM $3.58B
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$5.29B
AUM Growth
+$137M
Cap. Flow
-$177M
Cap. Flow %
-3.36%
Top 10 Hldgs %
25.42%
Holding
143
New
11
Increased
24
Reduced
86
Closed
7

Top Buys

Rank Stock Value
1
AMED
Amedisys
AMED
+$78.7M
2
EYE icon
National Vision
EYE
+$29.2M
3
FIVN icon
FIVE9
FIVN
+$27.9M
4
DHR icon
Danaher
DHR
+$27.8M
5
DSGX icon
Descartes Systems
DSGX
+$27.4M

Sector Composition

Rank Sector Weight
1 Technology 32.05%
2 Healthcare 20.84%
3 Industrials 18.54%
4 Consumer Discretionary 10%
5 Consumer Staples 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROL icon
26
Rollins
ROL
$18.3B
$75.2M 1.42%
3,144,087
+60,333
+2% +$1.56M
PS
27
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$75.2M 1.42%
2,479,168
+189,664
+8% +$6.09M
WST icon
28
West Pharmaceutical
WST
$24B
$72.8M 1.38%
581,996
-25,441
-4% -$3M
ECL icon
29
Ecolab
ECL
$78.1B
$69.9M 1.32%
354,031
-578
-0.2% -$107K
NEOG icon
30
Neogen
NEOG
$2.63B
$66.1M 1.25%
2,129,448
+442,286
+26% +$13M
FISV
31
Fiserv Inc
FISV
$28.8B
$65.8M 1.24%
721,398
-1,571
-0.2% -$138K
PCTY icon
32
Paylocity
PCTY
$7.38B
$65.3M 1.24%
696,218
-36,481
-5% -$3.46M
SBUX icon
33
Starbucks
SBUX
$120B
$64.7M 1.22%
772,165
-2,605
-0.3% -$204K
ALRM icon
34
Alarm.com
ALRM
$2.71B
$63.8M 1.21%
1,192,484
-44,455
-4% -$2.74M
TWOU
35
DELISTED
2U Inc
TWOU
$63.1M 1.19%
55,898
-2,276
-4% -$3.35M
AMZN icon
36
Amazon
AMZN
$2.92T
$60.2M 1.14%
635,940
+3,980
+0.6% +$371K
ADI icon
37
Analog Devices
ADI
$179B
$57.3M 1.08%
507,856
+6,075
+1% +$658K
WK icon
38
Workiva
WK
$3.36B
$56.7M 1.07%
975,998
-17,623
-2% -$944K
CRM icon
39
Salesforce
CRM
$151B
$53.7M 1.02%
353,823
-401
-0.1% -$62.8K
IFF icon
40
International Flavors & Fragrances
IFF
$20.2B
$49.3M 0.93%
339,706
-18,476
-5% -$2.57M
SPSC icon
41
SPS Commerce
SPSC
$2.64B
$49.2M 0.93%
963,056
-17,628
-2% -$919K
AMN icon
42
AMN Healthcare
AMN
$1.3B
$48.1M 0.91%
887,346
+153,330
+21% +$7.78M
USPH icon
43
US Physical Therapy
USPH
$1.2B
$47.6M 0.9%
388,244
-13,112
-3% -$1.51M
GWRE icon
44
Guidewire Software
GWRE
$12.6B
$47.3M 0.9%
466,922
-18,307
-4% -$1.87M
AYI icon
45
Acuity Brands
AYI
$9.83B
$45.5M 0.86%
329,793
+51,077
+18% +$7.02M
EXLS icon
46
EXL Service
EXLS
$5.14B
$45.1M 0.85%
3,412,605
-208,370
-6% -$2.56M
UNH icon
47
UnitedHealth
UNH
$376B
$43.8M 0.83%
179,619
-252
-0.1% -$60.6K
AOS icon
48
A.O. Smith
AOS
$8.17B
$43.3M 0.82%
918,444
+286,812
+45% +$14.1M
PRAA icon
49
PRA Group
PRAA
$663M
$38.7M 0.73%
1,376,059
-75,114
-5% -$2.12M
CHGG icon
50
Chegg
CHGG
$110M
$36M 0.68%
932,624
-28,175
-3% -$1.06M

Similar funds

Riverbridge Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Riverbridge Partners held 143 positions worth $5.29B, up 2.7% from $5.15B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Riverbridge Partners withdrew a net $177M in Q2 2019, closing 7 positions and reducing 86 holdings. Its most notable exit was Ultimate Software Group Inc, an estimated $162M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Riverbridge Partners opened a new position in Amedisys worth $80.5M.

  • Riverbridge Partners's largest Q2 2019 buy was Amedisys: 662,756 shares worth $80.5M.
  • Riverbridge Partners added most to BlackLine in Q2 2019, an estimated $23.9M increase.
  • Riverbridge Partners's biggest Q2 2019 reduction was HEICO Corp, cutting an estimated $65.7M.
  • Riverbridge Partners fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $162M.
  • Riverbridge Partners's ten largest holdings make up 25% of its $5.29B portfolio in Q2 2019.
  • Riverbridge Partners opened 11 new positions and closed 7 in Q2 2019.
  • Riverbridge Partners's portfolio value rose 2.7% quarter-over-quarter to $5.29B.

Based on Riverbridge Partners's 13F filing for Q2 2019, filed 10 Jul 2019.